Showing results (311-320 of 346) with videos related to
Sort By:
Pageof 35
Clinical Pharmacokinetics|December 4, 2013
Influence of gestational age and body weight on the pharmacokinetics of labetalol in pregnancyJames H Fischer, Gloria E Sarto, Jennifer Hardman, et al.Antimicrobial Agents and Chemotherapy|December 10, 2014
Assessment of time to clinical response, a proxy for discharge readiness, among hospitalized patients with community-acquired pneumonia who received either ceftaroline fosamil or ceftriaxone in two phase III FOCUS trialsThomas P Lodise, Antonio R Anzueto, David J Weber, et al.Infection Control and Hospital Epidemiology|October 24, 2009
Epidemiology and outcomes of hospitalizations with complicated skin and skin-structure infections: implications of healthcare-associated infection risk factorsMarya D Zilberberg, Andrew F Shorr, Scott T Micek, et al.The American Journal of Emergency Medicine|July 18, 2008
Health care-associated pneumonia: identification and initial management in the EDFredrick M Abrahamian, Peter M Deblieux, Charles L Emerman, et al.JAMA|December 23, 2004
Acute eosinophilic pneumonia among US Military personnel deployed in or near IraqAndrew F Shorr, Stephanie L Scoville, Steven B Cersovsky, et al.Journal of Clinical Microbiology|July 16, 2010
Clinical and economic outcomes for patients with health care-associated Staphylococcus aureus pneumoniaAndrew F Shorr, Nadia Haque, Charu Taneja, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 17, 2012
Linezolid in methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a randomized, controlled studyRichard G Wunderink, Michael S Niederman, Marin H Kollef, et al.Antimicrobial Agents and Chemotherapy|November 27, 2019
Polymyxin Susceptibility Testing and Interpretive Breakpoints: Recommendations from the United States Committee on Antimicrobial Susceptibility Testing (USCAST)Jason M Pogue, Ronald N Jones, John S Bradley, et al.Journal of Hospital Medicine|August 25, 2010
Clinical and economic outcomes in patients with community-acquired Staphylococcus aureus pneumoniaCharu Taneja, Nadia Haque, Gerry Oster, et al.Annals of Intensive Care|February 11, 2023
Outcomes in participants with ventilated nosocomial pneumonia and organ failure treated with ceftolozane/tazobactam versus meropenem: a subset analysis of the phase 3, randomized, controlled ASPECT-NP trialIgnacio Martin-Loeches, Andrew F Shorr, Richard G Wunderink, et al.Pageof 35